CN114075506B - Urine exosome extraction reagent tube and manufacturing method thereof - Google Patents
Urine exosome extraction reagent tube and manufacturing method thereof Download PDFInfo
- Publication number
- CN114075506B CN114075506B CN202010848912.XA CN202010848912A CN114075506B CN 114075506 B CN114075506 B CN 114075506B CN 202010848912 A CN202010848912 A CN 202010848912A CN 114075506 B CN114075506 B CN 114075506B
- Authority
- CN
- China
- Prior art keywords
- nanofiber membrane
- chitosan
- tube
- inner tube
- plla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000001808 exosome Anatomy 0.000 title claims abstract description 46
- 210000002700 urine Anatomy 0.000 title claims abstract description 23
- 238000000605 extraction Methods 0.000 title claims abstract description 21
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 7
- 239000012528 membrane Substances 0.000 claims abstract description 46
- 239000002121 nanofiber Substances 0.000 claims abstract description 34
- 238000006243 chemical reaction Methods 0.000 claims abstract description 6
- 229920001661 Chitosan Polymers 0.000 claims description 22
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 19
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 125000002091 cationic group Chemical group 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 229920002401 polyacrylamide Polymers 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- GRONZTPUWOOUFQ-UHFFFAOYSA-M sodium;methanol;hydroxide Chemical compound [OH-].[Na+].OC GRONZTPUWOOUFQ-UHFFFAOYSA-M 0.000 claims description 5
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 238000004132 cross linking Methods 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 229920000515 polycarbonate Polymers 0.000 claims description 3
- 239000004417 polycarbonate Substances 0.000 claims description 3
- 230000000284 resting effect Effects 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 abstract description 14
- 102000004895 Lipoproteins Human genes 0.000 abstract description 4
- 108090001030 Lipoproteins Proteins 0.000 abstract description 4
- 239000011148 porous material Substances 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 description 6
- 239000011324 bead Substances 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 238000000703 high-speed centrifugation Methods 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229950006137 dexfosfoserine Drugs 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 108020005198 Long Noncoding RNA Proteins 0.000 description 1
- 108700011259 MicroRNAs Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000006023 anti-tumor response Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- -1 circRNA Proteins 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000001926 trapping method Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/06—Tubular
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
- C12M33/10—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus by centrifugation ; Cyclones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
- C12M33/14—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus with filters, sieves or membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/04—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
- D01F8/14—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one polyester as constituent
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/18—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from other substances
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M10/00—Physical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. ultrasonic, corona discharge, irradiation, electric currents, or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements
- D06M10/001—Treatment with visible light, infrared or ultraviolet, X-rays
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M10/00—Physical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. ultrasonic, corona discharge, irradiation, electric currents, or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements
- D06M10/04—Physical treatment combined with treatment with chemical compounds or elements
- D06M10/08—Organic compounds
- D06M10/10—Macromolecular compounds
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/21—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/285—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of unsaturated carboxylic acid amides or imides
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/02—Natural fibres, other than mineral fibres
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/16—Synthetic fibres, other than mineral fibres
- D06M2101/30—Synthetic polymers consisting of macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M2101/32—Polyesters
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Textile Engineering (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Clinical Laboratory Science (AREA)
- Toxicology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a urine exosome extraction reagent tube and a manufacturing method thereof. The invention can complete the whole reaction in a short time without waiting for a long time; by utilizing the principle of positive and negative charge attraction, not only is no pollution caused by separating reagent, but also the uncharged lipoprotein with the particle size of 50-200nm in urine can be removed; the pore size of the positive charge porous nanofiber membrane is about 50-200nm, so that high-purity exosomes with particle sizes of 50-200nm can be obtained, and pollution of microvesicles with other particle sizes is prevented; the porous structure on the positively charged porous nanofiber membrane greatly improves the contact area between the membrane and a sample, and increases the extraction efficiency of urine exosomes.
Description
Technical Field
The invention relates to the technical field of exosome extraction, in particular to a urine exosome extraction reagent tube and a manufacturing method thereof.
Background
Exosomes were first found in 1981, EGTrams et al found vesicles with membrane structures in sheep red blood cell supernatants cultured in vitro and named exosomes. For exosome effects, it was speculated at the time that it was a way for cells to excrete waste. In 1996 GRaposo et al found that immune cells similar to B lymphocytes also secrete antigen presenting exosomes (anti-tumor) which directly stimulate the anti-tumor response of effector CD4+ cells. HValadi et al further found that genetic material can be exchanged between cells by RNA in exosomes. With the increasing research on exosomes, researchers have found that it is widely involved in various biological processes such as immune responses in the body, antigen presentation, cell differentiation, tumor growth invasion, etc.
Almost all types of cells secrete exosomes, while exosomes are also widely present in body fluids, including blood, tears, urine, saliva, milk, ascites fluid, and the like. The substances such as nucleic acid (microRNA, lncRNA, circRNA, mRNA, tRNA and the like), protein, cholesterol and the like carried by the exosomes can be effectively wrapped by the exosomes double-layer membrane, so the exosomes can resist degradation of various factors, the exosomes stably exist in body fluid, along with the deep research of the exosomes in recent years, obvious differences exist between the exosomes in body fluid of tumor patients in early stages of cancer onset and biological substances carried by normal human exosomes in clinic, and the exosomes extraction in body fluid is expected to become a cancer early diagnosis technology.
The extraction of urine exosomes at the present stage mainly comprises a super-high-speed centrifugation method, a magnetic bead antibody capturing method, a hue column size exclusion method, a PEG precipitation column passing method and a positive charge capturing method. Ultra-high speed centrifugation: ultracentrifugation is currently the most commonly used means of exosome purification, whereby vesicles of the same size are precipitated from a sample and purified by high-speed centrifugation. It is necessary to centrifuge the pellet (containing exosomes) in a centrifuge at 100,000-200,000Xg for 120 minutes. Magnetic bead antibody capture method: phosphoserine (PS) specific binding of Tim4 anchored magnetic beads on exosome membrane was then isolated by elution buffer containing EDTA. Hue column size exclusion method: the exosomes are separated from other particle size proteins according to their particle size. PEG precipitation column method: the exosomes are precipitated by PEG, then removed by ion column and finally eluted with high salt solution. Positive charge trapping method: and (3) covering a positively charged coating on the solid phase carrier, and capturing negatively charged exosomes by positive and negative charge attraction.
The existing exosome technology is time-consuming (40 min-10 h is not equal), pollution of extraction reagent with different degrees exists (such as precipitation reagent residue in PEG precipitation method, such as residue of high-salt reagent in column passing method, such as pollution of magnetic bead anchor chain antibody in magnetic bead adsorption method and pollution of eluent EDTA), positive charge capture can not cause pollution of extraction reagent, but micro vesicles with particle size of more than 200nm and exosomes with particle size of 50-200nm can not be distinguished, extraction efficiency of hue column size exclusion method on urine exosomes is low, a large amount of macromolecular substances contained in urine easily block hue column, and are easily polluted by lipoprotein with particle size of about 100 nm.
Disclosure of Invention
The invention aims to overcome the defects of the prior art, and provides a urine exosome extraction reagent tube.
In order to solve the technical problems, the invention provides the following technical scheme:
the invention relates to a urine exosome extraction reagent tube which comprises a cap, an outer tube and an inner tube, wherein the cap is sleeved on the top end surface of the outer tube in a threaded manner, the inner tube is sleeved in the outer tube, and a nanofiber membrane is arranged on the inner wall of the inner tube.
As a preferable technical scheme of the invention, the outer walls of the outer tube and the inner tube are provided with capacity scale marks, and the outer tube and the inner tube are made of polycarbonate materials.
The preparation method of the urine exosome extraction reagent tube provided by the invention comprises the following preparation steps:
a: dissolving PLLA with the molecular weight of 9 ten thousand and chitosan in a ratio of 5:1 in trifluoroethanol solution to prepare a mixed solution with the concentration of 8 weight percent, and fully dissolving the PLLA and chitosan mixed solution at the room temperature of 25-30 ℃;
b: advancing the syringe with a 27g needle at a high voltage of 8-10kV at a speed of 0.5-1.0ml/h, and receiving the nanofiber membrane with a resting plane;
c: putting the nanofiber membrane into a mixed solvent of ethanol and m-cresol, dissolving at room temperature of 25-30 ℃ for 60min, and drying;
d: soaking the membrane in 1.5mol/L sodium hydroxide methanol water solution for 30min to obtain a porous PLLA/chitosan nanofiber membrane;
e: adding 50mg of cationic polyacrylamide into 100ml of deionized water, heating to 50 ℃ and stirring, adjusting the pH value to 7.0 by NaOH, immersing a porous PLLA/chitosan nanofiber membrane into the solution, stirring at the room temperature of 25-30 ℃ for 24 hours, and drying;
f: irradiating for 3 hours by an ultraviolet lamp, and performing a crosslinking reaction on the cationic polyacrylamide and chitosan to obtain a positively charged porous PLLA/chitosan nanofiber membrane;
g: and (3) adhering the positively charged porous PLLA/chitosan nanofiber membrane on the inner wall of the inner tube, combining the inner tube 3 with the outer tube, and screwing a cap.
In the preparation method, the ratio of ethanol to m-cresol in the step C is 1:1.
In the preparation method, the ratio of methanol to water of the sodium hydroxide methanol aqueous solution in the step D is 1:1.
Compared with the prior art, the invention has the following beneficial effects:
the invention can complete the whole reaction in a short time without waiting for a long time; by utilizing the principle of positive and negative charge attraction, not only is no pollution caused by separating reagent, but also the uncharged lipoprotein with the particle size of 50-200nm in urine can be removed; the pore size of the positive charge porous nanofiber membrane is about 50-200nm, so that high-purity exosomes with particle sizes of 50-200nm can be obtained, and pollution of microvesicles with other particle sizes is prevented; the porous structure on the positively charged porous nanofiber membrane greatly improves the contact area between the membrane and a sample, and increases the extraction efficiency of urine exosomes.
Drawings
The accompanying drawings are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate the invention and together with the embodiments of the invention, serve to explain the invention. In the drawings:
FIG. 1 is a schematic view of the overall structure of the present invention;
FIG. 2 is a cross-sectional view of the structure of FIG. 1;
FIG. 3 is a flow chart of the positively charged porous PLLA/chitosan nanofiber membrane of the present invention;
FIG. 4 is a flow chart of urine exosome extraction of the present invention;
in the figure: 1. capping; 2. an outer tube; 3. an inner tube; 4. a nanofiber membrane.
Detailed Description
The preferred embodiments of the present invention will be described below with reference to the accompanying drawings, it being understood that the preferred embodiments described herein are for illustration and explanation of the present invention only, and are not intended to limit the present invention.
Example 1
As shown in fig. 1-4, the invention provides a urine exosome extraction reagent tube, which comprises a cap 1, an outer tube 2 and an inner tube 3, wherein the cap 1 is in threaded socket connection with the top surface of the outer tube 2, the inner tube 3 is in socket connection with the inner tube 2, and a nanofiber membrane 4 is arranged on the inner wall of the inner tube 3.
The outer walls of the outer tube 2 and the inner tube 3 are provided with capacity graduation marks, and the outer tube 2 and the inner tube 3 are made of polycarbonate materials.
The preparation method of the urine exosome extraction reagent tube comprises the following preparation steps:
a: dissolving PLLA with the molecular weight of 9 ten thousand and chitosan in a ratio of 5:1 in trifluoroethanol solution to prepare a mixed solution with the concentration of 8 weight percent, and fully dissolving the PLLA and chitosan mixed solution at the room temperature of 25-30 ℃;
b: advancing the syringe with a 27g needle at a high voltage of 8-10kV at a speed of 0.5-1.0ml/h, and receiving the nanofiber membrane with a resting plane;
c: putting the nanofiber membrane into a mixed solvent of ethanol and m-cresol, dissolving at room temperature of 25-30 ℃ for 60min, and drying;
d: soaking the membrane in 1.5mol/L sodium hydroxide methanol water solution for 30min to obtain a porous PLLA/chitosan nanofiber membrane;
e: adding 50mg of cationic polyacrylamide into 100ml of deionized water, heating to 50 ℃ and stirring, adjusting the pH value to 7.0 by NaOH, immersing a porous PLLA/chitosan nanofiber membrane into the solution, stirring at the room temperature of 25-30 ℃ for 24 hours, and drying;
f: irradiating for 3 hours by an ultraviolet lamp, and performing a crosslinking reaction on the cationic polyacrylamide and chitosan to obtain a positively charged porous PLLA/chitosan nanofiber membrane;
g: the positive charge porous PLLA/chitosan nanofiber membrane is adhered to the inner wall of the inner tube 3, and the cap 1 is screwed after the inner tube 3 and the outer tube 2 are combined.
Further, the ratio of ethanol to m-cresol in step C is 1:1.
In the step D, the ratio of methanol to water of the sodium hydroxide methanol aqueous solution is 1:1.
Specifically, when in use, the nanofiber membrane 4 on the inner wall of the inner tube 3 is a positively charged porous nanofiber membrane, firstly, 5ml of phosphate buffer solution is used for washing the nanofiber membrane 4 once, then 10ml of urine is sprayed on the nanofiber membrane 4 to cover the cover cap 1, the centrifugation is carried out for 1min to remove waste liquid, then 500ul of phosphate buffer solution is added to lightly wash the membrane once, the washing solution is sucked and removed to remove microvesicle components adhered on the membrane, finally 500ul of phosphate buffer solution is added to repeatedly wash the nanofiber membrane for 4 five times, the centrifugation is carried out for 1min at 1000rpm, and the membrane washing solution (the exosome with the diameter of 50-200 nm) is collected.
The invention can complete the whole reaction in a short time without waiting for a long time; by utilizing the principle of positive and negative charge attraction, not only is no pollution caused by separating reagent, but also the uncharged lipoprotein with the particle size of 50-200nm in urine can be removed; the pore size of the positive charge porous nanofiber membrane is about 50-200nm, so that high-purity exosomes with particle sizes of 50-200nm can be obtained, and pollution of microvesicles with other particle sizes is prevented; the porous structure on the positively charged porous nanofiber membrane greatly improves the contact area between the membrane and a sample, and increases the extraction efficiency of urine exosomes.
Finally, it should be noted that: the foregoing description is only a preferred embodiment of the present invention, and the present invention is not limited thereto, but it is to be understood that modifications and equivalents of some of the technical features described in the foregoing embodiments may be made by those skilled in the art, although the present invention has been described in detail with reference to the foregoing embodiments. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (4)
1. The manufacturing method of the urine exosome extraction reagent tube is characterized by comprising a cap (1), an outer tube (2) and an inner tube (3), wherein the cap (1) is sleeved on the top end surface of the outer tube (2) in a threaded manner, the inner tube (3) is sleeved in the outer tube (2), and a nanofiber membrane (4) is arranged on the inner wall of the inner tube (3), and the manufacturing steps are as follows:
a: dissolving PLLA with the molecular weight of 9 ten thousand and chitosan in a ratio of 5:1 in trifluoroethanol solution to prepare a mixed solution with the concentration of 8 weight percent, and fully dissolving the PLLA and chitosan mixed solution at the room temperature of 25-30 ℃;
b: advancing the syringe with a 27g needle at a high voltage of 8-10kV at a speed of 0.5-1.0ml/h, and receiving the nanofiber membrane with a resting plane;
c: putting the nanofiber membrane into a mixed solvent of ethanol and m-cresol, dissolving at room temperature of 25-30 ℃ for 60min, and drying;
d: soaking the membrane in 1.5mol/L sodium hydroxide methanol water solution for 30min to obtain a porous PLLA/chitosan nanofiber membrane;
e: adding 50mg of cationic polyacrylamide into 100ml of deionized water, heating to 50 ℃ and stirring, adjusting the pH value to 7.0 by NaOH, immersing a porous PLLA/chitosan nanofiber membrane into the solution, stirring at the room temperature of 25-30 ℃ for 24 hours, and drying;
f: irradiating for 3 hours by an ultraviolet lamp, and performing a crosslinking reaction on the cationic polyacrylamide and chitosan to obtain a positively charged porous PLLA/chitosan nanofiber membrane;
g: the positive charge porous PLLA/chitosan nanofiber membrane is adhered to the inner wall of the inner tube (3), and the inner tube (3) and the outer tube (2) are combined and then the cap (1) is screwed on.
2. The method for manufacturing the urine exosome extraction reagent tube according to claim 1, wherein capacity scale marks are arranged on the outer walls of the outer tube (2) and the inner tube (3), and the outer tube (2) and the inner tube (3) are made of polycarbonate materials.
3. The method of claim 1, wherein the ratio of ethanol to m-cresol in step C is 1:1.
4. The method of claim 1, wherein the ratio of methanol to water in the aqueous solution of sodium hydroxide and methanol in step D is 1:1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010848912.XA CN114075506B (en) | 2020-08-21 | 2020-08-21 | Urine exosome extraction reagent tube and manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010848912.XA CN114075506B (en) | 2020-08-21 | 2020-08-21 | Urine exosome extraction reagent tube and manufacturing method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114075506A CN114075506A (en) | 2022-02-22 |
CN114075506B true CN114075506B (en) | 2023-11-17 |
Family
ID=80282373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010848912.XA Active CN114075506B (en) | 2020-08-21 | 2020-08-21 | Urine exosome extraction reagent tube and manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114075506B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115786107A (en) * | 2022-12-14 | 2023-03-14 | 深圳市寰宇生物科技有限公司 | Efficient preparation device and method for exosome |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106283396A (en) * | 2016-08-22 | 2017-01-04 | 王利萍 | A kind of preparation method of porous chitosan fibrous membrane |
CN107254430A (en) * | 2017-08-11 | 2017-10-17 | 上海浦美生物医药科技有限公司 | A kind of method based on positive charge adsorbing separation excretion body |
CN209485829U (en) * | 2018-08-16 | 2019-10-11 | 南方医科大学 | The device of the workable enrichment urine excretion body of hospital and family |
-
2020
- 2020-08-21 CN CN202010848912.XA patent/CN114075506B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106283396A (en) * | 2016-08-22 | 2017-01-04 | 王利萍 | A kind of preparation method of porous chitosan fibrous membrane |
CN107254430A (en) * | 2017-08-11 | 2017-10-17 | 上海浦美生物医药科技有限公司 | A kind of method based on positive charge adsorbing separation excretion body |
CN209485829U (en) * | 2018-08-16 | 2019-10-11 | 南方医科大学 | The device of the workable enrichment urine excretion body of hospital and family |
Non-Patent Citations (2)
Title |
---|
A promising approach toward efficient isolation of the exosomes by core–shell PCL‑gelatin electrospun nanofibers;Fatemeh Barati1;Bioprocess and Biosystems Engineering;参见全文 * |
Novel label-free method for extracellular-vesicle enrichment from biological fluids and cell culture medium;Prateek Singh et al;ISEV2018 abstract book,,Journal of Extracellular Vesicles;第223页,PS04.14 * |
Also Published As
Publication number | Publication date |
---|---|
CN114075506A (en) | 2022-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chen et al. | Advances in exosomes technology | |
US20220349901A1 (en) | Lectin-macromolecule carrier coupling complex for separating glycosylated exosome in clinical sample | |
WO2006012886A1 (en) | Device and method for isolating cells, bioparticles and/or molecules from liquids for use with animals, in biotechnology, (including biotechnological research) and medical diagnostics | |
CN110231207B (en) | Method for separating exosome | |
CN114591905B (en) | Method for preparing apoptotic vesicles from human erythrocytes and application of apoptotic vesicles | |
CN114075506B (en) | Urine exosome extraction reagent tube and manufacturing method thereof | |
CN113101737B (en) | Affinity tangential flow filtration system, construction method thereof, exosome extraction method and application | |
CN110016435A (en) | A method of for the centrifugal microfluidic control chip of free nucleic acid extraction and its in extraction free nucleic acid | |
EP1712284A1 (en) | Cell separation method using hydrophobic solid supports | |
CN108387424B (en) | Preparation method and application of porous silicon material for biological sample pretreatment | |
CN112322584A (en) | Simple exosome extraction method | |
CN112195175A (en) | Nucleic acid extraction method based on graphene oxide | |
US8691559B2 (en) | Micro channel, device for recovering nucleic acid and method for recovering nucleic acid | |
CN113215079A (en) | Method for extracting extracellular vesicles from milk | |
CN114397388B (en) | Urine exosome extraction kit based on combination of PEG precipitation method and SEC column method and application | |
CN112014198B (en) | Kit and method for enriching endogenous low-molecular-weight proteins and polypeptides | |
JP4904973B2 (en) | Nucleic acid recovery method, nucleic acid recovery apparatus, and nucleic acid supply apparatus | |
JPWO2004048398A1 (en) | Method and apparatus for concentration and purification of nucleic acid | |
CN1990497A (en) | Method and apparatus for concentration and purification of nucleic acid | |
KR100714988B1 (en) | Method for DNA purification using bare surface of SiO2 structure,and Purification Apparatus thereby | |
CN113604465A (en) | Magnetic bead nucleic acid extraction method based on cetyl trimethyl ammonium bromide | |
CN112813027A (en) | Method for separating exosomes in urine | |
CN118006550B (en) | Method for extracting exosomes by using cell culture medium | |
CN115094030B (en) | Purification method of clinical-grade high-purity exosome | |
CN100415881C (en) | Device for pretreating specimen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |